Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53) - Image 1

£147.75

Springer Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Name: Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
Brand: Springer
Price: 147.75 GBP
Availability: InStock

Pharmacy - Dispensing

This is the most expensive it has ever been. Walk away.

£148 today · previous high £148 · all-time low £137

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 624 days • 624 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 624 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £147 (343 days, 55.0%)

Price range: £137 - £147

Price levels: 4 different prices over 624 days

Description

This book is based on invited presentations at the Ninth International Catecholamine Symposiwn. Over several decades, each International Catecholamine Symposiwn (ICS) has provided a uniquely important forwn for updating basic as well as clinical research on the catecholamines, dopamine, norepinephrine, and epinephrine. The first ICS took nd n1 place in Bethesda, Maryland, in the USA in 1958; the 2 in Milan, Italy in 1965; the 3 th in Strasbourg, France in 1973; the 4th in Asilomar, California, USA in 1978; the 5 in th th Goteborg, Sweden in 1983; the 6 in Jerusalem, Israel,in 1987; the 7 in Amsterdam, th Netherlands in 1992; and the 8 in Asilomar, California, USA in 1996. th The 9 International Catecholamine Symposiwn (9ICS) was held in Kyoto, Japan, th March 31-April 5, 2001. This ICS was held concurrently with the 5 International th Conference on Progress in Alzheimer's and Parkinson's Disease (5 ADPD). These international meetings were coordinated to be a joint international congress. Catecholamines and related neurotransmitters and neuromediators play important roles in the pathogenesis of symptoms and neurodegenerative processes of Alzheimer's disease and Parkinson's disease. Therefore, the Joint Congress provided an opportunity for investigators and clinicians working in these fields to exchange their· most recent investigational results and clinical experiences. This Joint International Congress turned out to be an enormous success, attended by 1258 participants from 38 countries, in an enthusiastic and pleasant atmosphere.

Product Specifications

Brand: Springer
Format: Paperback
ASIN: 1441933883
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 06 December 2010
Listed Since: 06 July 2010

Barcode

No barcode data available

Springer Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology)

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Advances in Neuropharmacology: Drugs and Therapeutics

Neurobiology of DOPA as a Neurotransmitter

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Progress in Alzheimer’s and Parkinson’s Diseases: 49 (Advances in Behavioral Biology, 49)

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)

Nicotinic Acetylcholine Receptors in the Nervous System: 25 (Nato ASI Subseries H:, 25)

Horizons in Neuroscience Research. Volume 15

Molecular Neuroscience

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)

Horizons in Neuroscience Research: Volume 37